These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 37459086)

  • 1. Efficacy of a Clinical Decision Rule to Enable Direct Oral Challenge in Patients With Low-Risk Penicillin Allergy: The PALACE Randomized Clinical Trial.
    Copaescu AM; Vogrin S; James F; Chua KYL; Rose MT; De Luca J; Waldron J; Awad A; Godsell J; Mitri E; Lambros B; Douglas A; Youcef Khoudja R; Isabwe GAC; Genest G; Fein M; Radojicic C; Collier A; Lugar P; Stone C; Ben-Shoshan M; Turner NA; Holmes NE; Phillips EJ; Trubiano JA
    JAMA Intern Med; 2023 Sep; 183(9):944-952. PubMed ID: 37459086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a penicillin allergy clinical decision rule to enable direct oral penicillin provocation: an international multicentre randomised control trial in an adult population (PALACE): study protocol.
    Copaescu AM; James F; Vogrin S; Rose M; Chua K; Holmes NE; Turner NA; Stone C; Phillips E; Trubiano J
    BMJ Open; 2022 Aug; 12(8):e063784. PubMed ID: 35940831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of a Penicillin Allergy Clinical Decision Rule.
    Trubiano JA; Vogrin S; Chua KYL; Bourke J; Yun J; Douglas A; Stone CA; Yu R; Groenendijk L; Holmes NE; Phillips EJ
    JAMA Intern Med; 2020 May; 180(5):745-752. PubMed ID: 32176248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral challenge vs routine care to assess low-risk penicillin allergy in critically ill hospital patients (ORACLE): a pilot safety and feasibility randomised controlled trial.
    Rose MT; Holmes NE; Eastwood GM; Vogrin S; James F; De Luca JF; Bellomo R; Warrillow SJ; Phung M; Barnes SL; Murfin B; Rogers B; Lambros B; Collis B; Peel TN; Slavin MA; Trubiano JA
    Intensive Care Med; 2024 Jun; 50(6):913-921. PubMed ID: 38739277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors of amoxicillin immediate hypersensitivity and validation of PEN-FAST clinical decision rule.
    Piotin A; Godet J; Trubiano JA; Grandbastien M; Guénard-Bilbault L; de Blay F; Metz-Favre C
    Ann Allergy Asthma Immunol; 2022 Jan; 128(1):27-32. PubMed ID: 34271183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing Direct Challenge to Penicillin Skin Testing for the Outpatient Evaluation of Penicillin Allergy: A Randomized Controlled Trial.
    Mustafa SS; Conn K; Ramsey A
    J Allergy Clin Immunol Pract; 2019; 7(7):2163-2170. PubMed ID: 31170542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct oral amoxicillin challenge without preliminary skin testing in adult patients with allergy and at low risk with reported penicillin allergy.
    Kuruvilla M; Shih J; Patel K; Scanlon N
    Allergy Asthma Proc; 2019 Jan; 40(1):57-61. PubMed ID: 30582497
    [No Abstract]   [Full Text] [Related]  

  • 8. In low-risk penicillin allergies, direct oral challenge was noninferior to skin testing followed by oral challenge.
    Aung K; Htay T
    Ann Intern Med; 2023 Nov; 176(11):JC127. PubMed ID: 37931260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the Effectiveness of Penicillin Allergy De-labeling.
    Bourke J; Pavlos R; James I; Phillips E
    J Allergy Clin Immunol Pract; 2015; 3(3):365-34.e1. PubMed ID: 25609352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol for a systematic review and meta-analysis of interventions aimed at delabeling low-risk penicillin allergies with consideration for sex and gender.
    Maximos M; Elsayed S; Maxwell C; Houle SKD; Pelletier R; McConnell B; Pylypiak A; Gamble JM
    Syst Rev; 2024 Oct; 13(1):259. PubMed ID: 39402648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of oral penicillin challenge in low-risk penicillin allergy.
    Drug Ther Bull; 2024 Mar; 62(4):51. PubMed ID: 38527765
    [No Abstract]   [Full Text] [Related]  

  • 12. Inpatient allergy delabeling of pediatric patients with low-risk penicillin allergy status through direct oral amoxicillin challenge.
    Lim PPC; Moore LN; Minich NM; Wessell KR; Desai AP
    Allergy Asthma Proc; 2024 Jan; 45(1):61-69. PubMed ID: 38151739
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral challenge vs routine care to assess low-risk penicillin allergy in critically ill hospital patients (ORACLE): a pilot randomised controlled trial.
    Rose M; Holmes N; Eastwood G; Vogrin S; James F; Phung M; Barnes S; Murfin B; Rogers B; Lambros B; Peel T; Gibney G; Slavin M; Trubiano J
    Pilot Feasibility Stud; 2023 Jul; 9(1):126. PubMed ID: 37475038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De-labelling self-reported penicillin allergy within the emergency department through the use of skin tests and oral drug provocation testing.
    Marwood J; Aguirrebarrena G; Kerr S; Welch SA; Rimmer J
    Emerg Med Australas; 2017 Oct; 29(5):509-515. PubMed ID: 28378949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Penicillin Allergy Delabeling Program: A Multicenter Whole-of-Hospital Health Services Intervention and Comparative Effectiveness Study.
    Chua KYL; Vogrin S; Bury S; Douglas A; Holmes NE; Tan N; Brusco NK; Hall R; Lambros B; Lean J; Stevenson W; Devchand M; Garrett K; Thursky K; Grayson ML; Slavin MA; Phillips EJ; Trubiano JA
    Clin Infect Dis; 2021 Aug; 73(3):487-496. PubMed ID: 32756983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The challenge of de-labeling penicillin allergy.
    Stone CA; Trubiano J; Coleman DT; Rukasin CRF; Phillips EJ
    Allergy; 2020 Feb; 75(2):273-288. PubMed ID: 31049971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving routine prenatal penicillin allergy testing for reported penicillin allergy.
    Gill MM; Gasner S; Banken A; Park M; Weaver A; Sharpe E; Theiler R
    BMJ Open Qual; 2022 Jul; 11(3):. PubMed ID: 35906008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a Pharmacist-Led Penicillin Allergy Assessment Program and Allergy Delabeling in a Tertiary Care Hospital.
    Turner NA; Wrenn R; Sarubbi C; Kleris R; Lugar PL; Radojicic C; Moehring RW; Anderson DJ
    JAMA Netw Open; 2021 May; 4(5):e219820. PubMed ID: 33983399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter Australian Study to Determine Criteria for Low- and High-Risk Penicillin Testing in Outpatients.
    Stevenson B; Trevenen M; Klinken E; Smith W; Yuson C; Katelaris C; Perram F; Burton P; Yun J; Cai F; Barnes S; Spriggs K; Ojaimi S; Mullins R; Salman S; Martinez P; Murray K; Lucas M
    J Allergy Clin Immunol Pract; 2020 Feb; 8(2):681-689.e3. PubMed ID: 31604129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.